Sera from Remitting and Secondary Progressive Multiple Sclerosis Patients Disrupt the Blood-Brain Barrier (original) (raw)
Sera from Patients with Multiple Sclerosis in Relapse or Remission Affect the Blood-Brain Barrier Differently: An In vitro Study
Radu Tanasescu
SVOA Neurology, 2022
View PDFchevron_right
Role of the Blood-Brain Barrier in Multiple Sclerosis
Miguel Angel Macias
Archives of Medical Research, 2014
View PDFchevron_right
Neuronal and BBB damage induced by sera from patients with secondary progressive multiple sclerosis
Giuseppe Salemi
International Journal of Molecular Medicine, 2009
View PDFchevron_right
Blood-brain barrier disruption in multiple sclerosis
Ruben Van Doorn
Multiple Sclerosis, 2003
View PDFchevron_right
Inflammatory Proprotein Convertase-Matrix Metalloproteinase Proteolytic Pathway in Antigen-presenting Cells as a Step to Autoimmune Multiple Sclerosis
Alex Strongin
Journal of Biological Chemistry, 2009
View PDFchevron_right
Diverse Targets for Intervention during Inflammatory and Neurodegenerative Phases of Multiple Sclerosis
Lawrence Steinman, Scott Zamvil
Neuron, 2003
View PDFchevron_right
Multiple Sclerosis and the Blood-Central Nervous System Barrier
Alan Palmer
2013
View PDFchevron_right
The immunology of multiple sclerosis
Judith Greer
Current Opinion in Neurology, 1994
View PDFchevron_right
Autoantibodies to myelin basic protein (MBP) in healthy individuals and in patients with multiple sclerosis: a role in regulating cytokine responses to MBP
C. Nielsen
…, 2009
View PDFchevron_right
Send Orders for Reprints to reprints@benthamscience.ae Molecular Approach to Targeted Therapy for Multiple Sclerosis
JavCaballero Vllrr
View PDFchevron_right
NEW CONCEPTS IN THE IMMUNOPATHOGENESIS OF MULTIPLE SCLEROSIS
Hans-peter Hartung
Nature Reviews Neuroscience, 2002
View PDFchevron_right
B cells in MS and NMO: pathogenesis and therapy
Edgar Meinl
Seminars in Immunopathology, 2014
View PDFchevron_right
Immunology of multiple sclerosis
Judith Greer
Current Allergy and Asthma Reports, 2007
View PDFchevron_right
Emerging roles of endothelial cells in multiple sclerosis pathophysiology and therapy
Jeanie McGee
Neurological Research, 2012
View PDFchevron_right
Reviewing the Significance of Blood–Brain Barrier Disruption in Multiple Sclerosis Pathology and Treatment
Doina Manu
2021
View PDFchevron_right
Antigen microarrays identify CNS-produced autoantibodies in RRMS
Francisco Leo Quintana
Neurology, 2012
View PDFchevron_right
Effects of rIFN-beta-1b on serum circulating ICAM-1 in relapsing remitting multiple sclerosis and on the membrane-bound ICAM-1 expression on brain microvascular endothelial cells
Maria Trojano
Journal of neurovirology, 2000
View PDFchevron_right
Adhesion molecules on endothelial cells in the central nervous system: An emerging area in the neuroimmunology of multiple sclerosis
Anne Cross
Clinical Immunology and Immunopathology, 1990
View PDFchevron_right
Adhesion Molecules in Multiple Sclerosis: Relation to Subtypes of Disease and Methylprednisolone Therapy
Terho Lehtimäki
2000
View PDFchevron_right
Dynamics of the reactivity to MBP in multiple sclerosis
Francesco Caroli
Journal of neurovirology, 2000
View PDFchevron_right
Inflammation-induced endothelial to mesenchymal transition promotes brain endothelial cell dysfunction and occurs during multiple sclerosis pathophysiology
Helga De Vries
Cell Death & Disease, 2019
View PDFchevron_right
Multiple sclerosis: elevated expression of matrix metalloproteinases in blood monocytes
Mathilde Kouwenhoven
Journal of Autoimmunity, 2001
View PDFchevron_right
Blood–brain barrier disruption and enhanced vascular permeability in the multiple sclerosis model EAE
Anita Kollar
Journal of Neuroimmunology, 2010
View PDFchevron_right
The B cell response in multiple sclerosis
Jeffrey Bennett
Neurological Research, 2006
View PDFchevron_right
Seric immune complexes in multiple sclerosis do not contain MBP epitopes
Michel Geffard
Brain Research Bulletin, 1993
View PDFchevron_right
The effects of blood–brain barrier disruption on glial cell function in multiple sclerosis
Una Fitzgerald
Biochemical Society Transactions, 2009
View PDFchevron_right
Soluble vascular cell adhesion molecule (VCAM) is associated with treatment effects of Interferon beta-1b in patients with Secondary Progressive Multiple Sclerosis
F. Dahlke
Journal of Neurology, 2005
View PDFchevron_right
Immunopathophysiologic basis of multiple sclerosis and implications for therapy-a narrative review
Jan Redfern
Pharmacy & Pharmacology International Journal, 2021
View PDFchevron_right
The myelin-associated oligodendrocytic basic protein (MOBP) as a relevant primary target autoantigen in multiple sclerosis
Nathali Kaushansky, Miriam Eisenstein
Autoimmunity Reviews, 2010
View PDFchevron_right
B cell characterization and reactivity analysis in multiple sclerosis
Marc De Baets, Mario Losen, Veerle Somers
Autoimmunity Reviews, 2009
View PDFchevron_right
Restricted use of VH4 Germline segments in an acute multiple sclerosis brain
M. Burgoon
Annals of Neurology, 1998
View PDFchevron_right